Seoul, South Korea

Seok Jun Moon

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Seok Jun Moon: Innovator in Health-Related Pharmaceuticals

Introduction

Seok Jun Moon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of health-related pharmaceuticals, particularly in the areas of obesity and bone-related diseases. With a total of 2 patents, his work is recognized for its potential impact on public health.

Latest Patents

Seok Jun Moon's latest patents include a composition for preventing or treating obesity or lipid-related metabolic disorders. This functional composition utilizes a steroid sulfatase inhibitor as an active ingredient, aiming to address the growing concerns of obesity and metabolic issues. Another notable patent is a pharmaceutical composition for the treatment of bone-related diseases. This innovative composition not only promotes the differentiation of preosteoblast cells into osteoblasts, leading to the production of mineralized nodules, but also inhibits the differentiation and function of osteoclasts. This dual action effectively regulates bone homeostasis, making it particularly beneficial for menopausal bone diseases.

Career Highlights

Seok Jun Moon is currently associated with Nexyon Biotech Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving health outcomes through innovative pharmaceutical solutions.

Collaborations

Seok Jun Moon collaborates with notable colleagues, including Jung Taek Seo and Sung-Jin Kim. Their combined expertise enhances the research and development initiatives at Nexyon Biotech Co., Ltd.

Conclusion

Seok Jun Moon's contributions to the field of pharmaceuticals demonstrate his dedication to addressing critical health issues. His innovative patents reflect a promising future for treatments related to obesity and bone health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…